SAShereen K Ali

Shereen K Ali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shereen K Ali has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artemisia herba-alba sesquiterpenes: in silico inhibition in the ATP-binding pocket

    by Tarik A. Mohamed, Mohamed H. Abd El-Razek, Ibrahim A. Saleh, Sherin K. Ali, Abeer A. Abd El Aty, Paul W. Paré, Mohamed-Elamir F. Hegazy

    To identify antimicrobial leads for medical applications, metabolites from the aerial part of Artemisia herba-alba were extracted and chromatographically purified.


  • Open Access

    Sarcoconvolutums F and G: Polyoxygenated Cembrane-Type Diterpenoids from Sarcophyton convolutum, a Red Sea Soft Coral

    by Tarik A. Mohamed, Abdelsamed I. Elshamy, Mohamed H. Abd El-Razek, Asmaa M. Abdel-Tawab, Sherin K. Ali, Mohamed Aboelmagd, Midori Suenaga, Paul W. Pare, Akemi Umeyama, Mohamed-Elamir F. Hegazy

    Natural products and chemical analogues are widely used in drug discovery, notably in cancer and infectious disease pharmacotherapy. Sarcophyton convolutum (Alcyoniidae) a Red Sea–derived soft coral has been shown to be a rich source of macrocyclic diterpenes and cyclized derivatives. Two previously undescribed polyoxygenated cembrane-type diterpenoids, sarcoconvolutums F (1) and G (2), as well as four identified analogues (3–6) together with a furan derivate (7) were isolated from a solvent extract. Compounds were identified by spectroscopic techniques, including NMR, HREIMS, and CD, together with close spectral comparisons of previously published data. Sarcoconvolutum F (1) contains a rare 1-peroxid-15-hydroxy-10-ene functionality. Isolated metabolites (1–7) were screened against lung adenocarcinoma (A549), cervical cancer (HeLa) and oral cavity carcinoma (HSC-2) lines. Compound 4 exhibited an IC50 56 µM and 55 µM against A549 and HSC-2 cells, respectively.


  • Open Access

    Gastroprotection against Rat Ulcers by Nephthea Sterol Derivative

    by Tarik A. Mohamed, Abdelsamed I. Elshamy, Mahmoud A. A. Ibrahim, Mohamed A. M. Atia, Rania F. Ahmed, Sherin K. Ali, Karam A. Mahdy, Shifaa O. Alshammari, Ahmed M. Al-Abd, Mahmoud F. Moustafa, et al.

    Different species belonging to the genus Nephthea (Acyonaceae) are a rich resource for bioactive secondary metabolites. The literature reveals that the gastroprotective effects of marine secondary metabolites have not been comprehensively studied in vivo. Hence, the present investigation aimed to examine and determine the anti-ulcer activity of 4α,24-dimethyl-5α-cholest-8β,18-dihydroxy,22E-en-3β-ol (ST-1) isolated from samples of a Nephthea species. This in vivo study was supported by in silico molecular docking and protein–protein interaction techniques. Oral administration of ST-1 reduced rat stomach ulcers with a concurrent increase in gastric mucosa. Molecular docking calculations against the H+/K+-ATPase transporter showed a higher binding affinity of ST-1, with a docking score value of −9.9 kcal/mol and a pKi value of 59.7 nM, compared to ranitidine (a commercial proton pump inhibitor, which gave values of −6.2 kcal/mol and 27.9 µM, respectively). The combined PEA-reactome analysis results revealed promising evidence of ST-1 potency as an anti-ulcer compound through significant modulation of the gene set controlling the PI3K signaling pathway, which subsequently plays a crucial role in signaling regarding epithelialization and tissue regeneration, tissue repairing and tissue remodeling. These results indicate a probable protective role for ST-1 against ethanol-induced gastric ulcers.


  • The potential of cultivated milk thistle by-products as cancer chemopreventive and anti-inflammatory drugs

    by Sherin K Ali, Nahla S Abdel-Azim, Ali K Khalil, Mohamed-Elamir F Hegazy, TarikA Mohamed, Ahmed R Hamed, KhaledA Shams, Faiza M Hammouda

    Background and objectives Seeds of Silybum marianum (milk thistle), growing wild in Egypt, have been used since ancient times in traditional medicine. This study aims at identifying chemical and bioactivity properties of the oil of the seeds of cultivated S. marianum, obtained by cold pressing, as well as the extracts of the leaves. The prepared extracts were tested for their cancer chemoprevention and anti-inflammatory activities. Materials and methods The phytochemical constituents of cold-pressed seed oil and extracts of the leave were determined using gas chromatography–mass spectrometry and high-performance liquid chromatography (HPLC), respectively. The prepared extracts were tested for their cancer chemopreventive and anti-inflammatory activities. Results and conclusion HPLC profiling of leaves extract indicated that gallic acid and naringenin are the major phenolic acid and flavonoid, respectively. Additionally, HPLC analyses indicated the presence of seven main active components of silymarin in seeds. The total extract from leaves caused a moderate NAD(P)H-quinone oxidoreductase 1 protein induction and inducible nitric oxide synthase protein expression inhibition. Conclusion Cultivated S. marianum (milk thistle) by-products (oil and leaves) could have possible applications in food and pharmaceutical industry


  • Open Access

    In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer disease

    by Shereen K Ali, Ahmed R Hamed, Maha M Soltan, Usama M Hegazy, Esameldin E Elgorashi, Ibrahim A El-Garf, Ahmed A Hussein

    Background: Egyptians recognized the healing power of herbs and used them in their medicinal formulations. Nowadays, “Attarin” drug shops and the public use mainly the Unani medicinal system for treatment of their health problems including improvement of memory and old age related diseases. Numerous medicinal plants have been described in old literature of Arabic traditional medicine for treatment of Alzheimer’s disease (AD) (or to strengthen memory).Methods: In this study, some of these plants were evaluated against three different preliminary bioassays related to AD to explore the possible way of their bio-interaction. Twenty three selected plants were extracted with methanol and screenedin vitroagainst acetylcholinesterase (AChE) and cycloxygenase-1 (COX-1) enzymes. In addition, anti-oxidant activity using DPPH was determined.Results: Of the tested plant extracts;Adhatoda vasicaandPeganum harmalashowed inhibitory effect on AChE at IC50294 μg/ml and 68 μg/ml respectively. Moreover,A. vasicainteracted reversibly with the enzyme whileP. harmalashowed irreversible inhibition.Ferula assafoetida(IC503.2 μg/ml),Syzygium aromaticum(34.9 μg/ml) andZingiber officinalis(33.6 μg/ml) showed activity against COX-1 enzyme. Potent radical scavenging activity was demonstrated by three plant extractsTerminalia chebula(EC502.2 μg/ml),T. arjuna(3.1 μg/ml) andEmblica officinalis(6.3 μg/ml).Conclusion: Interestingly, differential results have been obtained which indicate the variability of the mode of actions for the selected plants. Additionally, the reversible interaction ofA. vasicaagainst AChE and the potent activity ofF. assafoetidaagainst COX-1 make them effective, new and promising agents for treatment of AD in the future, either as total extracts or their single bioactive constituents.